Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients
Status:
Completed
Trial end date:
2018-12-14
Target enrollment:
Participant gender:
Summary
Compare the difference in dose-normalized trough and total daily dose necessary to reach the
steady state therapeutic goal after conversion from tacrolimus IR to Astagraf XL® in African
American kidney transplant recipients.